alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 87, Number 65 (Tuesday, April 5, 2022)]
[Notices]
[Page 19690]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-07115]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Therapeutic Development and Preclinical Studies.
    Date: April 14, 2022.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Richard D Schneiderman, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4138, Bethesda, MD 20817, 301-
402-3995, <a href="/cdn-cgi/l/email-protection#90e2f9f3f8f1e2f4bee3f3f8fef5f9f4f5e2fdf1fed0fef9f8bef7ffe6"><span class="__cf_email__" data-cfemail="50223933383122347e2333383e35393435223d313e103e39387e373f26">[email protected]</span></a>.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: March 30, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-07115 Filed 4-4-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
HCI VIOCARE







NOTICE OF STOCK AWARD


CHRISTOS KAPATOS of resident of 66 Stewarton Drive, Cambuslang, Glasgow G72 8DG, Scotland, UK, you have been granted a stock award of the Common Stock (the "Common Stock") of HCI Viocare as follows:







	
Grant number:

	 	
0017


	
Date of Grant:

	 	
December 12, 2017


	
Vesting Commencement Date:

	 	
See vesting schedule below


	
Total Number of Award Shares Granted:

	 	
18,500,000 COMMON SHARES


	
Term/Expiration Date:

	 	
N/A


	 	 	 








VESTING SCHEDULE:  This Award may be issued, in whole or in part, in accordance with the following schedule:
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8237 Introduced in House (IH)]

<DOC>

116th CONGRESS
  2d Session
                                H. R. 8237

    To amend title 38, United States Code, to clarify the scope of 
procedural rights of members of the uniformed services with respect to 
   their employment and reemployment rights, and for other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 14, 2020

Mr. Cicilline (for himself, Mr. Takano, Mr. Reschenthaler, Mr. Golden, 
Mrs. Davis of California, Mr. Wilson of South Carolina, and Mr. Johnson 
 of Georgia) introduced the following bill; which was referred to the 
                     Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
    To amend title 38, United States Code, to clarify the scope of 
procedural rights of members of the uniformed services with respect to 
   their employment and reemployment rights, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting the Employment Rights of 
Servicemembers Act''.

SEC. 2. CLARIFICATIONS REGARDING SCOPE OF EMPLOYMENT AND REEMPLOYMENT 
              RIGHTS OF MEMBERS OF THE UNIFORMED SERVICES.

    (a) Clarification Regarding Definition of Rights and Benefits.--
Section 4303(2) of title 38, United States Code, is amended--
            (1) by inserting ``(A)'' before ``The term''; and
            (2) by adding at the end the following new subparagraph:
            ``(B) Any procedural protections or provisions set forth in 
        this chapter shall also be considered a right or benefit 
        subject to the protection of this chapter.''.
    (b) Clarification Regarding Relation to Other Law and Plans for 
Agreements.--Section 4302 of such title is amended by adding at the end 
the following:
    ``(c)(1) Pursuant to this section and the procedural rights 
afforded by subchapter III of this chapter, any agreement to arbitrate 
a claim under this chapter is unenforceable, unless all parties consent 
to arbitration after a complaint on the specific claim has been filed 
in court or with the Merit Systems Protection Board and all parties 
knowingly and voluntarily consent to have that particular claim 
subjected to arbitration.
    ``(2) For purposes of this subsection, consent shall not be 
considered voluntary when a person is required to agree to arbitrate an 
action, complaint, or claim alleging a violation of this chapter as a 
condition of future or continued employment, advancement in employment, 
or receipt of any right or benefit of employment.''.
                                 <all>
```
| (logo) WELLS            FARGO | **Corporate Trust Services**MAC R1204-0109062 Old Annapolis RoadColumbia, MD 21045Tel: 410 884 2000 Fax: 410 715 2380 |
|---------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------|

 

 

Morgan Stanley Capital I Inc. 

1585 Broadway

New York, New York 10036

 

 

RE: Annual Statement of Compliance for Morgan Stanley Bank of America Merrill Lynch Trust 2014-C19, Commercial Mortgage Pass-Through Certificates Series 2014-C19

 

Per the Pooling and Servicing Agreement dated as of December 1, 2014 (the "Agreement"), the undersigned, a duly authorized officer of Wells Fargo Bank, N.A., as Certificate Administrator ("Wells Fargo"), hereby certifies as follows as of and for the year ending December 31, 2015 (the "Reporting Period"):

 

(a) A review of Wells Fargo's activities during the Reporting Period and of its performance under the Agreement has been made under such officer's supervision; and

 

(b) To the best of such officer's knowledge, based on such review, Wells Fargo has fulfilled all of its obligations under the Agreement in all material respects throughout the Reporting Period.

 

 

March 1, 2016

 

 

/s/ Brian Smith

BRIAN SMITH

Vice President 

 

 

Wells Fargo Bank, N.A.
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

NATIONAL VEHICLE AND FUEL EMISSIONS LABORATORY

2000 TRAVERWOOD DRIVE

ANN ARBOR, MI 48105-2498

 OFFICE OF

AIR AND RADIATION

July 9, 2012

MEMORANDUM

SUBJECT: 25x’25 Alliance Meeting with EPA Regarding Proposal for 2017-2025 Light-Duty

(LD) Greenhouse Gas (GHG) Standards

FROM: Ed Nam, US EPA

TO: EPA Docket # EPA-HQ-OAR-2010-0799

This memo documents a meeting held (by phone) on July 5, 2012 between representatives of 

25x’25 Alliance and EPA to discuss comments submitted June 28, 2012 by 25x’25 Alliance on 

the LD GHG proposed rule. They discussed the high level messages from their comments. The 

following people were present:

From EPA: Bill Charmley, Jeff Alson, and Edward Nam

From 25x'25: Ernie Shae, Roger Johnson, and Brian Jennings
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 08-6988

CALVIN MCCROREY, JR., Defendant - Appellant,
v. UNITED STATES OF AMERICA, Plaintiff - Appellee. Appeal from the United States District Court for the District of South Carolina, at Rock Hill. Joseph F. Anderson, Jr., Chief District Judge. (0:98-cr-01186-JFA-11) Submitted: September 11, 2008 Decided: September 17, 2008 Before WILKINSON and NIEMEYER, Circuit Judges, and HAMILTON, Senior Circuit Judge. Dismissed by unpublished per curiam opinion.. Calvin McCrorey, Jr., Appellant Pro Se. Marshall Prince, II, Assistant United States Attorney, Columbia, South Carolina, for Appellee. Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Calvin McCrorey, Jr., seeks to appeal the district court’s order treating his Fed. R. Civ. P. 60(b) motion as a successive 28 U.S.C. § 2255 (2000) motion, and dismissing it on that basis. The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1) (2000); Reid v. Angelone , 369 F.3d 363, 369 (4th Cir. 2004). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2000). A prisoner satisfies this standard by demonstrating that reasonable jurists would find that any assessment of the constitutional claims by the district court is debatable or wrong and that any dispositive procedural ruling by the district court is likewise debatable. Miller-El v. Cockrell , 537 U.S. 322, 336-38 (2003); Slack v. McDaniel , 529 U.S. 473, 484 (2000); Rose v. Lee , 252 F.3d 676, 683-84 (4th Cir. 2001). We have independently reviewed the record and conclude that McCrorey has not made the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the appeal. Additionally, we construe McCrorey’s notice of appeal and informal brief as an application to file a second or successive motion under 28 U.S.C. § 2255. United States v. Winestock, 340 F.3d 200, 208 (4th Cir. 2003). In order to obtain authorization to file a successive § 2255 motion, a prisoner must assert claims3 based on either: (1) a new rule of constitutional law, previously unavailable, made retroactive by the Supreme Court to cases on collateral review; or (2) newly discovered evidence, not previously discoverable by due diligence, that would be sufficient to establish by clear and convincing evidence that, but for constitutional error, no reasonable factfinder would have found the movant guilty of the offense. 28 U.S.C. §§ 2244(b)(2), 2255 (2000). McCrorey’s claims do not satisfy either of these criteria. Therefore, we deny authorization to file a successive § 2255 motion. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT
No. 95-7129
KIM LEIGHTON MCBRIDE, Petitioner - Appellant, versus L. T. LESTER, Respondent - Appellee.
Appeal from the United States District Court for the Eastern District of Virginia, at Norfolk. Raymond A. Jackson, District Judge. (CA-95-341-2) Submitted: February 7, 1996 Decided: February 21, 1996 Before MURNAGHAN and WILLIAMS, Circuit Judges, and PHILLIPS, Senior Circuit Judge. Dismissed by unpublished per curiam opinion. Kim Leighton McBride, Appellant Pro Se. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: Appellant noted this appeal outside the thirty-day appeal period established by Fed. R. App. P. 4(a)(1), failed to obtain an extension of the appeal period within the additional thirty-day period provided by Fed. R. App. P. 4(a)(5), and is not entitled to relief under Fed. R. App. P. 4(a)(6). The time periods established by Fed. R. App. P. 4 are "mandatory and jurisdictional." Browder v. Director, Dep't of Corrections , 434 U.S. 257, 264 (1978) (quoting United States v. Robinson , 361 U.S. 220, 229 (1960)). The district court entered its order on June 16, 1995; Appellant's notice of appeal was filed on July 26, 1995. Appellant's failure to note a timely appeal or obtain an extension of the appeal period deprives this court of jurisdiction to consider this case. We therefore deny a certificate of probable cause to appeal, deny leave to proceed in forma pauperis, and di smiss the appeal. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

DISMISSED
Exhibit 10.5


 


Annual Compensation of Non-Employee Directors


 


	Name/Position	 	2014 
Retainer	 	 	2013 
Retainer	 	 	2012 
Retainer	 
	Martin S. Friedman, Non-Employee Director	 	$	36,000	 	 	$	36,000	 	 	$	36,000	 
	Thomas M. Kody, Non-Employee Director	 	$	36,000	 	 	$	36,000	 	 	$	36,000	 
	John W. Edgemond IV, Non-Employee Director	 	$	36,000	 	 	$	36,000	 	 	$	36,000	 
	J. Randolph Babbitt, Non-Employee Director	 	$	36,000	 	 	$	36,000	 	 	$	12,000	 
	James L. Jadlos, Chairman and Non-Employee Director	 	$	48,000	 	 	$	48,000	 	 	$	48,000	 
	Michael G. Anzilotti, Non-Employee Director	 	$	33,000	 	 	$	-	 	 	$	-	 



 


The Non-Employee Directors will be paid the 2014 retainer in
quarterly installments in the month following the end of each fiscal quarter.
Exhibit
31.1



CERTIFICATION
BY PRINCIPAL EXECUTIVE OFFICER



I,
Lishan Aklog, M.D., certify that:



|1. | I
    have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of PAVmed Inc.; and                                                                                                                                                                                                                        
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                                                                                                                                                                       
|2. | Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report.



|Date:
    April 24, 2020 | By: | /s/
    Lishan Aklog, M.D.                                                                       
|------------------------ | --- | -------------------------------------------------------------------------------------------------
|                         |     | Lishan
        Aklog, M.D., Chief Executive Officer
        (Principal
        Executive Officer)
Exhibit 32.1





CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Broadcaster, Inc. (the Company) on Form 10-Q for the period ending March 31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), I Martin Wade, III, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:



1.

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and



2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                                         
|-----------------------------------------
|                                         
|/s/ Martin Wade III                      
|Martin Wade, III,
Chief Executive Officer



Date:  May 20, 2008



A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit 10.8

 

Waiver

 

This waiver is made in connection with the Agreement, dated July 13, 2004 by and among Meitav Technological Enterprises Initiation Center Ltd., Yehuda Zafrir Feidin, Yissum- the Company for the Development of Research of the Hebrew University of Jerusalem (“Yissum”) and Professor Oded Shoseyov (the “Agreement”):

 

Yissum hereby agrees that Section 14.7 (including all sub-sections) of the Agreement (“Section 14.7”) is no longer viable, and Yissum hereby, on behalf of itself and its legal successors and assigns, irrevocably and perpetually waives any and all rights it and its legal successors and assigns may be entitled to under Section 14.7, and deems section 14.7 as void and cancelled, effective as of the date of execution of this document by Yissum.

 

In witness whereof, Yissum hereby sets its signature on this 4th day of September 2017.

 

Yissum- the Company for the Development of Research of the Hebrew University of Jerusalem

 

	
By:
    	
/s/ Ariela Markel, M.Sc., MBA
    	
 
    
	
Name:
    	
VP Licensing, Biotechnology
    	
 
    
	
Title:
    	
/s/ Dr. Yaron Daniely, CEO of   Yissum
    	
 
    


 

Received, agreed and accepted on September 10th, 2017

 

Collplant Ltd.

 

	
By:
    	
/s/ Yehiel Tal
    	
 
    	
 
    	
/s/ Eran Rotem
    	
 
    
	
Name:
    	
Yehiel Tal
    	
 
    	
 
    	
Eran Rotem
    	
 
    
	
Title:
    	
CEO
    	
 
    	
 
    	
CFO
# Journal officiel C 117A/3 av

| | ISSN 1977-0936 |
| --- | --- |
| Journal officiel
  de l'Union européenne | C 117A |
| | |
| Édition de langue française | Communications et informations | 61e année3 avril 2018 |

ISSN 1977-0936

Journal officiel

de l'Union européenne

C 117A

Édition de langue française

Communications et informations

61e année3 avril 2018

---

| Numéro d'information | Sommaire | page |
| --- | --- | --- |
| | V   Avis |
| | PROCÉDURES ADMINISTRATIVES |
| | Office européen de sélection du personnel (EPSO) |
| 2018/C 117 A/01 | Addendum à la liste de réserve — Concours général EUIPO/AST/02/17 — Assistants (AST 3) dans le domaine de la propriété intellectuelle | 1 |

Numéro d'information

Sommaire

page

V   Avis

PROCÉDURES ADMINISTRATIVES

Office européen de sélection du personnel (EPSO)

2018/C 117 A/01

Addendum à la liste de réserve — Concours général EUIPO/AST/02/17 — Assistants (AST 3) dans le domaine de la propriété intellectuelle

1

---

| FR | |
| --- | --- |

FR

---

V Avis

PROCÉDURES ADMINISTRATIVES

Office européen de sélection du personnel (EPSO)

| 3.4.2018 | FR | Journal officiel de l'Union européenne | CA 117/1 |
| --- | --- | --- | --- |

3.4.2018

FR

Journal officiel de l'Union européenne

CA 117/1

---

ADDENDUM À LA LISTE DE RÉSERVE

Concours général EUIPO/AST/02/17

Assistants (AST 3) dans le domaine de la propriété intellectuelle

(2018/C 117 A/01)

| DE LA CUEVA CARABINE | Samantha |
| --- | --- |

DE LA CUEVA CARABINE

Samantha

La validité de cette liste expirera le 30 juin 2021.

---
#### UNITED STATES of America, Plaintiff-Appellee v. Galdina RANGEL-CALDERON, Defendant-Appellant

No. 16-41700 Conference Calendar

United States Court of Appeals, Fifth Circuit.

Filed February 20, 2018

Carmen Castillo Mitchell, Assistant U.S. Attorney, U.S. Attorney’s Office, Southern District of Texas, Houston, TX, for Plaintiff-Appellee

Galdina Rangel-Calderon, Pro Se

Before REAVLEY, CLEMENT, and HO, Circuit Judges.

PER CURIAM: *

The attorney appointed to represent Galdina Rangel-Calderon has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), and *United States v. Flores,*632 F.3d 229 (5th Cir. 2011). Rangel-Calderon has not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

JESUS MACHADO,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

No. 4D18-2282

[November 1, 2018]

Appeal of order denying 3.850 motion from the Circuit Court for the 

Seventeenth Judicial Circuit, Broward County; Dennis D. Bailey, Judge; 

L.T. Case No. 061998CF011617A88810.

Jesus Machado, Lowell, pro se.

No appearance required for appellee.

PER CURIAM.

Affirmed.

MAY, CONNER and KUNTZ, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          12,303
<SECURITIES>                                         0
<RECEIVABLES>                                   56,675
<ALLOWANCES>                                     1,190
<INVENTORY>                                     10,981
<CURRENT-ASSETS>                                95,758
<PP&E>                                         827,271
<DEPRECIATION>                                 346,044
<TOTAL-ASSETS>                                 610,850
<CURRENT-LIABILITIES>                           83,193
<BONDS>                                        251,742
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           311
<OTHER-SE>                                     240,085
<TOTAL-LIABILITY-AND-EQUITY>                   610,850
<SALES>                                        143,869
<TOTAL-REVENUES>                               170,025
<CGS>                                                0
<TOTAL-COSTS>                                   37,685
<OTHER-EXPENSES>                                85,709
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              16,820
<INCOME-PRETAX>                                 20,206
<INCOME-TAX>                                     8,417
<INCOME-CONTINUING>                             11,789
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,789
<EPS-PRIMARY>                                      .33
<EPS-DILUTED>                                      .33
        

</TABLE>